The Effect of the FDA VVarning on the Use of Droperidol by U.S. Emergency Physicians

The Effect of the FDA VVarning on the Use of Droperidol by U.S. Emergency Physicians

Objectives: To determine if emergency physicians' (EP) use droperidol has changed since the United States Food and Drug Administration (FDA) warning of December 2001 concerning QT interval prolongation, torsade de pointes, and sudden death; and to query EP opinions regarding droperidol before a...

Full description

Bibliographic Details
Main Authors: Richards, John R, Weiss, Steven J, Bretz, Stephen W, Schneir, Aaron B, Rinetti, Dauna, Derlet, Robert W
Format: Article
Language:English
Published: eScholarship Publishing, University of California 2003-01-01
Series:Western Journal of Emergency Medicine
Subjects:
droperidol
Inapsine
emergency medicine
FDA warning
Online Access:http://escholarship.org/uc/item/0vh5m5rf

Internet

http://escholarship.org/uc/item/0vh5m5rf

Similar Items